• HIV Epidemiology, Routine Testing and Linkage to Care

    Presenter: Dayna Morrison, MPH & Melissa D. Murphy, MD
    Original Date: November 18, 2015

    As the ACA shifts the burden of managing HIV to primary care, the OR AIDS Education and Training Center is committed to providing ongoing education to ensure best practices and high quality medical care for people living with HIV/AIDS. This webinar series provides primary care providers with up to date information on prevention, disease management, linkage to specialty care, and drug interactions to increase primary care capacity to serve this population. 

    This presentation covers HIV epidemiology and the importance of routine testings. Viewers learn how to link patients to care in Oregon and SW Washington and better understand the role of DIS.

    1.5 general CEUs approved by OBNM
  • HIV Prevention and PreExposure Prophylaxis (PrEP)

    Christopher Evans, MD/MPH, AAHIVM & Angela Carter, ND
    Original Date: December 9, 2015

    This presentation focuses on treatment as prevention and the role of PrEP. Dr. Evans shares tools to facilitate discussions with patients about their risk behaviors and covers how Pre-Exposure Prophylaxis can be used to prevent new HIV infections. Also covered are  contraindications to prescribing PrEP, ongoing patient management (including labs), and short and long term side effects of undergoing therapy

    1.5 pharmacy CEUs approved by OBNM
  • Natural History/Pathogenesis of HIV

    Presenter: Melissa D. Murphy, MD
    Original Date: January 13, 2016

    In this presentation Dr. Murphy covers the recognition of Opportunistic Infections. She discusses the appropriate use of antiretroviral therapy and importance of starting therapy shortly after diagnosis.

    1.5 CEUs (including 0.5 pharmacy and 1.0 general) approved by OBNM
  • Antiretroviral Therapy Overview and Drug-Drug Interactions

    Presenter: Devon Flynn, PharmD, BCPS
    Original Date: February 10, 2016

    In this presentation Dr. Flynn cover antiretroviral therapy and the importance of starting therapy shortly after diagnosis. Viewers are taught key drug drug interactions with ARVs to ensure positive health outcomes for patients.

    1.5 pharmacy CEUs approved by OBNM

Privacy Policy